COVIVIO (COV.PA) Stock Fundamental Analysis
Europe - EPA:COV - FR0000064578 - REIT
55.45 EUR
-0.95 (-1.68%)
Overall COV gets a fundamental rating of 3 out of 10. We evaluated COV against 41 industry peers in the Diversified REITs industry. COV has a medium profitability rating, but doesn't score so well on its financial health evaluation. COV has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
COV had positive earnings in the past year.
COV had a positive operating cash flow in the past year.
Of the past 5 years COV 4 years were profitable.
In the past 5 years COV always reported a positive cash flow from operatings.
1.2 Ratios
COV has a Return On Assets (1.63%) which is comparable to the rest of the industry.
With a Return On Equity value of 5.08%, COV perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
COV's Return On Invested Capital of 3.21% is in line compared to the rest of the industry. COV outperforms 47.37% of its industry peers.
The Average Return On Invested Capital over the past 3 years for COV is in line with the industry average of 3.46%.
The 3 year average ROIC (2.97%) for COV is below the current ROIC(3.21%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.63% | ||
| ROE | 5.08% | ||
| ROIC | 3.21% |
ROA(3y)-1.05%
ROA(5y)0.29%
ROE(3y)-3.48%
ROE(5y)0.76%
ROIC(3y)2.97%
ROIC(5y)2.68%
1.3 Margins
COV has a Profit Margin (30.46%) which is in line with its industry peers.
COV's Profit Margin has declined in the last couple of years.
The Operating Margin of COV (57.81%) is worse than 68.42% of its industry peers.
COV's Operating Margin has been stable in the last couple of years.
COV has a Gross Margin (74.42%) which is in line with its industry peers.
In the last couple of years the Gross Margin of COV has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 57.81% | ||
| PM (TTM) | 30.46% | ||
| GM | 74.42% |
OM growth 3Y-1.46%
OM growth 5Y-1.11%
PM growth 3Y-61.53%
PM growth 5Y-38.78%
GM growth 3Y-2.18%
GM growth 5Y-0.89%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), COV is destroying value.
COV has more shares outstanding than it did 1 year ago.
COV has more shares outstanding than it did 5 years ago.
The debt/assets ratio for COV has been reduced compared to a year ago.
2.2 Solvency
COV has an Altman-Z score of 0.53. This is a bad value and indicates that COV is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of COV (0.53) is worse than 71.05% of its industry peers.
The Debt to FCF ratio of COV is 28.44, which is on the high side as it means it would take COV, 28.44 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 28.44, COV is doing worse than 76.32% of the companies in the same industry.
COV has a Debt/Equity ratio of 1.07. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.07, COV is doing worse than 81.58% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.07 | ||
| Debt/FCF | 28.44 | ||
| Altman-Z | 0.53 |
ROIC/WACC0.55
WACC5.81%
2.3 Liquidity
COV has a Current Ratio of 0.76. This is a bad value and indicates that COV is not financially healthy enough and could expect problems in meeting its short term obligations.
COV has a Current ratio of 0.76. This is in the better half of the industry: COV outperforms 68.42% of its industry peers.
A Quick Ratio of 0.69 indicates that COV may have some problems paying its short term obligations.
COV has a better Quick ratio (0.69) than 65.79% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.76 | ||
| Quick Ratio | 0.69 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 5.98% over the past year.
Measured over the past years, COV shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.39% on average per year.
The Revenue has grown by 27.96% in the past year. This is a very strong growth!
The Revenue has been growing slightly by 1.17% on average over the past years.
EPS 1Y (TTM)5.98%
EPS 3Y0.91%
EPS 5Y-3.39%
EPS Q2Q%6.25%
Revenue 1Y (TTM)27.96%
Revenue growth 3Y9.01%
Revenue growth 5Y1.17%
Sales Q2Q%-30.61%
3.2 Future
COV is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.36% yearly.
Based on estimates for the next years, COV will show a small growth in Revenue. The Revenue will grow by 2.88% on average per year.
EPS Next Y5.08%
EPS Next 2Y3.25%
EPS Next 3Y3.36%
EPS Next 5YN/A
Revenue Next Year-1.08%
Revenue Next 2Y1.65%
Revenue Next 3Y2.88%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 12.03, which indicates a correct valuation of COV.
Based on the Price/Earnings ratio, COV is valued a bit cheaper than 68.42% of the companies in the same industry.
COV is valuated cheaply when we compare the Price/Earnings ratio to 25.89, which is the current average of the S&P500 Index.
COV is valuated reasonably with a Price/Forward Earnings ratio of 11.64.
Compared to the rest of the industry, the Price/Forward Earnings ratio of COV is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.59, COV is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.03 | ||
| Fwd PE | 11.64 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as COV.
Based on the Price/Free Cash Flow ratio, COV is valued a bit more expensive than 68.42% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.73 | ||
| EV/EBITDA | 16.97 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates COV does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)2.37
PEG (5Y)N/A
EPS Next 2Y3.25%
EPS Next 3Y3.36%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 6.21%, COV is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.79, COV pays a bit more dividend than its industry peers.
COV's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.21% |
5.2 History
The dividend of COV decreases each year by -1.54%.
Dividend Growth(5Y)-1.54%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
92.95% of the earnings are spent on dividend by COV. This is not a sustainable payout ratio.
DP92.95%
EPS Next 2Y3.25%
EPS Next 3Y3.36%
EPA:COV (11/14/2025, 7:00:00 PM)
55.45
-0.95 (-1.68%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners41.52%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap6.19B
Revenue(TTM)1.37B
Net Income(TTM)417.86M
Analysts81.25
Price Target64.44 (16.21%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.21% |
Yearly Dividend0.72
Dividend Growth(5Y)-1.54%
DP92.95%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.29%
PT rev (3m)1.08%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.85%
Revenue NY rev (3m)-1.14%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.03 | ||
| Fwd PE | 11.64 | ||
| P/S | 4.51 | ||
| P/FCF | 15.73 | ||
| P/OCF | 6.17 | ||
| P/B | 0.75 | ||
| P/tB | 0.79 | ||
| EV/EBITDA | 16.97 |
EPS(TTM)4.61
EY8.31%
EPS(NY)4.77
Fwd EY8.59%
FCF(TTM)3.52
FCFY6.36%
OCF(TTM)8.99
OCFY16.22%
SpS12.29
BVpS73.66
TBVpS70.57
PEG (NY)2.37
PEG (5Y)N/A
Graham Number87.41
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.63% | ||
| ROE | 5.08% | ||
| ROCE | 3.59% | ||
| ROIC | 3.21% | ||
| ROICexc | 3.42% | ||
| ROICexgc | 3.48% | ||
| OM | 57.81% | ||
| PM (TTM) | 30.46% | ||
| GM | 74.42% | ||
| FCFM | 28.68% |
ROA(3y)-1.05%
ROA(5y)0.29%
ROE(3y)-3.48%
ROE(5y)0.76%
ROIC(3y)2.97%
ROIC(5y)2.68%
ROICexc(3y)3.08%
ROICexc(5y)2.79%
ROICexgc(3y)3.11%
ROICexgc(5y)2.81%
ROCE(3y)3.32%
ROCE(5y)3%
ROICexgc growth 3Y12.16%
ROICexgc growth 5Y0.31%
ROICexc growth 3Y11.77%
ROICexc growth 5Y0.14%
OM growth 3Y-1.46%
OM growth 5Y-1.11%
PM growth 3Y-61.53%
PM growth 5Y-38.78%
GM growth 3Y-2.18%
GM growth 5Y-0.89%
F-Score7
Asset Turnover0.05
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.07 | ||
| Debt/FCF | 28.44 | ||
| Debt/EBITDA | 9.39 | ||
| Cap/Depr | 417.19% | ||
| Cap/Sales | 44.51% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 106.87% | ||
| Profit Quality | 94.14% | ||
| Current Ratio | 0.76 | ||
| Quick Ratio | 0.69 | ||
| Altman-Z | 0.53 |
F-Score7
WACC5.81%
ROIC/WACC0.55
Cap/Depr(3y)709.28%
Cap/Depr(5y)708.5%
Cap/Sales(3y)50.08%
Cap/Sales(5y)56.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.98%
EPS 3Y0.91%
EPS 5Y-3.39%
EPS Q2Q%6.25%
EPS Next Y5.08%
EPS Next 2Y3.25%
EPS Next 3Y3.36%
EPS Next 5YN/A
Revenue 1Y (TTM)27.96%
Revenue growth 3Y9.01%
Revenue growth 5Y1.17%
Sales Q2Q%-30.61%
Revenue Next Year-1.08%
Revenue Next 2Y1.65%
Revenue Next 3Y2.88%
Revenue Next 5YN/A
EBIT growth 1Y-0.73%
EBIT growth 3Y7.42%
EBIT growth 5Y0.05%
EBIT Next Year12.82%
EBIT Next 3Y8.12%
EBIT Next 5Y8.08%
FCF growth 1Y42.08%
FCF growth 3YN/A
FCF growth 5Y31.13%
OCF growth 1Y30.56%
OCF growth 3Y12.5%
OCF growth 5Y4.86%
COVIVIO / COV.PA FAQ
Can you provide the ChartMill fundamental rating for COVIVIO?
ChartMill assigns a fundamental rating of 3 / 10 to COV.PA.
What is the valuation status of COVIVIO (COV.PA) stock?
ChartMill assigns a valuation rating of 4 / 10 to COVIVIO (COV.PA). This can be considered as Fairly Valued.
Can you provide the profitability details for COVIVIO?
COVIVIO (COV.PA) has a profitability rating of 4 / 10.
What is the earnings growth outlook for COVIVIO?
The Earnings per Share (EPS) of COVIVIO (COV.PA) is expected to grow by 5.08% in the next year.
Can you provide the dividend sustainability for COV stock?
The dividend rating of COVIVIO (COV.PA) is 4 / 10 and the dividend payout ratio is 92.95%.